Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 1173 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Improving Access to Chimeric Antigen Receptor T-cells for Refractory or Relapsing Diffuse Large B Cell Lymphoma Therapy in Asia
Ya Hwee Tan,Dok Hyun Yoon, Andrew J. Davies, Christian Buske, Yang Liang Boo,Nagavalli Somasundaram, Francesca Lim, Shin Yeu Ong, Anand Jeyasekharan, Koji Izutsu,Won Seog Kim,Jason Yongsheng Chan
Discover Oncologyno. 1 (2025): 1-13
Cited0Views0WOSBibtex
0
0
Supplementary Data 1 from A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas
Won Seog Kim,Jake Shortt,Pier Luigi Zinzani, Natalia Mikhailova, Dejan Radeski, Vincent Ribrag, Eva Domingo Domenech,Ahmed Sawas, Karenza Alexis, Michael Emig, Riham Elbadri, Pallavi Hajela,Paulien Ravenstijn, Sheena Pinto, Linta Garcia,Andre Overesch, Kerstin Pietzko,Steven Horwitz
crossref（2025）
Cited0Views0Bibtex
0
0
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Nancy L Bartlett,Uwe Hahn,Won-Seog Kim,Isabelle Fleury,Kamel Laribi, Juan-Miguel Bergua,Krimo Bouabdallah,Nicholas Forward,Fontanet Bijou,David MacDonald,Craig A Portell,Herve Ghesquieres,Grzegorz Nowakowski,Christopher A Yasenchak, Monica Patterson, Linda Ho, Evelyn Rustia,Michelle Fanale, Fei Jie,Jeong-A Kim
Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2402242-JCO2402242, (2025)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 1220

#Citation: 33367

H-Index: 83

G-Index: 149

Sociability: 9

Diversity: 4

Activity: 128

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn